Hiyoshi M, Eltalkhawy Y, Abdelnaser R, Ono A, Monde K, Maeda Y
PLoS Pathog. 2025; 21(1):e1012919.
PMID: 39869648
PMC: 11801699.
DOI: 10.1371/journal.ppat.1012919.
Bellon M, Jain P, Nicot C
Viruses. 2024; 16(11).
PMID: 39599870
PMC: 11599126.
DOI: 10.3390/v16111755.
Joseph J, Premeaux T, Tandon R, Murphy E, Bruhn R, Nicot C
Viruses. 2024; 16(9).
PMID: 39339919
PMC: 11436225.
DOI: 10.3390/v16091443.
Carcone A, Mortreux F, Alais S, Mathieu C, Journo C, Dutartre H
PLoS Pathog. 2024; 20(9):e1012555.
PMID: 39283919
PMC: 11426526.
DOI: 10.1371/journal.ppat.1012555.
Bellon M, Nicot C
Int J Mol Sci. 2024; 25(10).
PMID: 38791169
PMC: 11120950.
DOI: 10.3390/ijms25105130.
Establishment of a novel human T-cell leukemia virus type 1 infection model using cell-free virus.
Nagata K, Tezuka K, Kuramitsu M, Fuchi N, Hasegawa Y, Hamaguchi I
J Virol. 2024; 98(2):e0186223.
PMID: 38294250
PMC: 10878273.
DOI: 10.1128/jvi.01862-23.
Interaction of TSG101 with the PTAP Motif in Distinct Locations of Gag Determines the Incorporation of HTLV-1 Env into the Retroviral Virion.
Maeda Y, Monde K, Terasawa H, Tanaka Y, Sawa T
Int J Mol Sci. 2023; 24(22).
PMID: 38003710
PMC: 10671467.
DOI: 10.3390/ijms242216520.
Therapeutic approaches for HTLV-1-associated adult T-cell leukemia/lymphoma: a comprehensive review.
Letafati A, Soheili R, Norouzi M, Soleimani P, Mozhgani S
Med Oncol. 2023; 40(10):295.
PMID: 37689806
DOI: 10.1007/s12032-023-02166-8.
Milk Transmission of Mammalian Retroviruses.
Kemeter L, Birzer A, Heym S, Thoma-Kress A
Microorganisms. 2023; 11(7).
PMID: 37512949
PMC: 10386362.
DOI: 10.3390/microorganisms11071777.
Recent Updates on Viral Oncogenesis: Available Preventive and Therapeutic Entities.
Chowdhary S, Deka R, Panda K, Kumar R, Solomon A, Das J
Mol Pharm. 2023; 20(8):3698-3740.
PMID: 37486263
PMC: 10410670.
DOI: 10.1021/acs.molpharmaceut.2c01080.
Mechanisms of Innate Immune Sensing of HTLV-1 and Viral Immune Evasion.
Mohanty S, Harhaj E
Pathogens. 2023; 12(5).
PMID: 37242405
PMC: 10221045.
DOI: 10.3390/pathogens12050735.
How Can We Prevent Mother-to-Child Transmission of HTLV-1?.
Itabashi K, Miyazawa T, Uchimaru K
Int J Mol Sci. 2023; 24(8).
PMID: 37108125
PMC: 10138424.
DOI: 10.3390/ijms24086961.
Hijacking Host Immunity by the Human T-Cell Leukemia Virus Type-1: Implications for Therapeutic and Preventive Vaccines.
Pise-Masison C, Franchini G
Viruses. 2022; 14(10).
PMID: 36298639
PMC: 9609126.
DOI: 10.3390/v14102084.
A role for an HTLV-1 vaccine?.
Ratner L
Front Immunol. 2022; 13:953650.
PMID: 36159878
PMC: 9497876.
DOI: 10.3389/fimmu.2022.953650.
Co-Infection and Cancer: Host-Pathogen Interaction between Dendritic Cells and HIV-1, HTLV-1, and Other Oncogenic Viruses.
Mulherkar T, Gomez D, Sandel G, Jain P
Viruses. 2022; 14(9).
PMID: 36146843
PMC: 9503663.
DOI: 10.3390/v14092037.
An acquired phosphatidylinositol 4-phosphate transport initiates T-cell deterioration and leukemogenesis.
Zhong W, Lin W, Yang Y, Chen D, Cao X, Xu M
Nat Commun. 2022; 13(1):4390.
PMID: 35906240
PMC: 9338045.
DOI: 10.1038/s41467-022-32104-7.
Is the HTLV-1 Retrovirus Targeted by Host Restriction Factors?.
Carcone A, Journo C, Dutartre H
Viruses. 2022; 14(8).
PMID: 35893677
PMC: 9332716.
DOI: 10.3390/v14081611.
Deconvolution of Adult T-Cell Leukemia/Lymphoma With Single-Cell RNA-Seq Using Frozen Archived Skin Tissue Reveals New Subset of Cancer-Associated Fibroblast.
Joo E, Bae J, Park J, Bang Y, Han J, Gulati N
Front Immunol. 2022; 13:856363.
PMID: 35464471
PMC: 9021607.
DOI: 10.3389/fimmu.2022.856363.
Milk Transmission of HTLV-1 and the Need for Innovative Prevention Strategies.
Millen S, Thoma-Kress A
Front Med (Lausanne). 2022; 9:867147.
PMID: 35360738
PMC: 8962517.
DOI: 10.3389/fmed.2022.867147.
Regulation of HTLV-1 transformation.
Ernzen K, Panfil A
Biosci Rep. 2022; 42(3).
PMID: 35169839
PMC: 8919135.
DOI: 10.1042/BSR20211921.